• Foresight sets primary goal to sell prototype systems of QuadSight, its multi-spectral vision system for autonomous vehicles
• The company looks to establish mutual cooperation with key clients in automotive industry
• Foresight moves forward with plans to sell its Eyes-On automotive vision system to a leading Israeli vehicle importer
• Global autonomous vehicle market expected to reach $54.23 billion by 2026

While 2017 was the year of the electric vehicle, 2018 is slated to be the year of autonomy. Elon Musk predicted a fully autonomous Tesla (NASDAQ: TSLA) model by 2018, and General Motors Company (NYSE: GM) is slated to put its version of a fully autonomous car into production in 2019 (http://ibn.fm/E1B0r) (http://ibn.fm/4Fj3c). The global autonomous vehicle market is expected to reach $54.23 billion by 2026 (http://ibn.fm/zG5aG). Well positioned to take advantage of the upcoming autonomous vehicle boom is Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), a technological innovator in automotive vision systems and driver assistance technology working to solve the complex nuances of autonomous driving.

Foresight creates products and solutions designed to drive the future of the semi- and fully-autonomous vehicle industry. The company was first conceptualized as a spin-off of major shareholder Magna B.S.P., an Israeli company that has provided innovative homeland security and surveillance technology solutions for the last 20 years. Foresight now uses the same technology to power two of its unique solutions: QuadSight and Eyes-On. Foresight’s third solution, EyeNet, is a cellular-based V2X accident prevention system.

Foresight recently signed a non-binding memorandum of understanding (“MOU”) with a leading importer of vehicles to Israel for the sale of its Eyes-On system for aftermarket configuration. As a first step, Foresight and the importer will carry out a pilot project using a beta version of the Eyes-On system during which the system will be integrated into a number of models from the importer’s fleet of vehicles. The MOU could potentially see the importer order 21,000 Eyes-On systems over three years. Eyes-On is an advanced driver assistance system (“ADAS”) that uses two cameras and stereoscopic technology to detect potential obstacles with a very high degree of accuracy. Stereoscopic technology uses two synchronized cameras to imitate human depth perception. Eyes-On is available as both an OEM and a retrofit solution.

Foresight’s focus for 2018 is QuadSight, according to a recent interview given by VP of Business Development Doron Cohadier. QuadSight is a multi-spectral vision system that uses four cameras (two visible light and two infrared cameras) to provide safety in all weather and lighting conditions, including extreme weather situations. One of Foresight’s main goals for this year is the sale of several QuadSight prototype systems. Foresight recently sold a couple of these prototype systems.

“These prototype systems will allow us to be in connection with various key stakeholders within the automotive industry at an early stage,” Cohadier explained in a news release. “And following that, we want to establish mutual cooperation with these key clients in the automotive industry.”

Foresight’s operates as a holding company with three pillars under it: Foresight Automotive Ltd., Eye-Net and Rail Vision. Foresight Automotive is dedicated to developing advanced accident prevention systems and solutions based on vision systems and stereoscopic technology, while EyeNet is focused on development of the EyeNet V2X (vehicle-to-everything) cellular-based accident prevention system that provides real-time pre-collision alerts to vehicles and pedestrians using smartphones and cellular networks. Rail Vision, of which Foresight has 35 percent equity, develops advanced systems for railway safety.

Another large goal for Foresight in 2018 is to complete the spinoff and merger of Eye-Net with Israeli company Tamda Ltd. (TASE: TMDA). The two companies signed a merger agreement in early May that will see Foresight establish a wholly owned subsidiary. Foresight will then transfer to the subsidiary all of Foresight’s rights and intellectual property for Eye-Net for no consideration. Upon closure of the merger, Foresight has agreed to transfer 100 percent of the share capital of the newly-created subsidiary to Tamda in exchange for approximately 74.49 percent of Tamda’s share capital as of the closing date of the transaction.

Foresight is well-positioned to reach these goals. The company recently attracted private placement agreements from several leading Israeli institutional investors. Harel Insurance invested $5.5 million, while Meitav Dash Group invested $4.1 million and Psagot Investment House another $1.4 million.

Cohadier also spoke to Foresight’s strong strategic positioning, saying “At the end of the day, an autonomous vehicle will have a few technologies on them for sensors for redundancy purposes. Basically, there won’t be one winning technology, there will be quite a few. But what we understood is vision will always be needed. Vision is the only sensor that can actually identify lanes, traffic signs, traffic lights, colours… If vision will always be needed and you require [it], you might as well have the best vision systems. We want to provide the market with the best vision systems.”

For more information, visit the company’s website at www.ForesightAuto.com

• LXRP files for patent with the USPTO for DehydraTECH’s innovative treatment options for diseases and disorders including Alzheimer’s, Huntington’s and Parkinson’s
• Company hopes to leverage this future possible patent to commercialize its development or out-licensing of future new products that treat central nervous system diseases
• DehydraTECH platform, being lab tested for drug delivery, effectively transported nicotine across the blood brain barrier, a barrier that protects the brain and makes traditional treatment difficult

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) patented DehydraTECH™ drug delivery platform has already received some eight patents granted and nearly 50 pending worldwide, and the company has applied for one more to the USPTO. This is because, in lab studies, the proprietary technology has shown evidence of transporting active pharmaceutical ingredients (APIs) across the brain’s protective blood brain barrier, the company announced in an article published by the CFN Media Group (http://ibn.fm/OOv4A).

That barrier blocks blood borne circulating toxins and is a challenge to researchers trying to deliver APIs in medications past it. The barrier serves as a significant hindrance for drug treatment of diseases of the central nervous system. DehydraTECH technology, in animal lab tests, was able to transport more nicotine to the brain tissue, conjugating or joining with APIs for maximum delivery.

Based in British Columbia, Canada, LXRP is a biotechnology company that out-licenses its disruptive delivery technology that promotes healthier ingestion methods. It results in lower dosing and higher effectiveness. LXRP holds a patent for oral delivery of all cannabinoids. It has a growing IP portfolio and will license in any of the 40 countries worldwide where its technology already has a patent or is patent-pending. DehydraTECH is its proprietary delivery technology platform.

LXRP has conducted in vivo lab studies on animals to, in part, determine DehydraTECH’s ability to deliver enhanced levels of nicotine to the bloodstream and brain tissue. The studies found that this platform was able to deliver up to 560 percent greater amounts of nicotine to the brain tissue compared to controls without DehydraTECH.

Originally, the tests were focused on developing products for nicotine replacement by LXRP (http://ibn.fm/GtEeg), which is itself a multi-billion market with profound need for more effective alternatives. However, the tests demonstrated that DehydraTECH could effectively transport drugs, in this case nicotine, across the blood brain barrier. The diseases affected include Alzheimer’s, Parkinson’s, Huntington’s, schizophrenia, depression, anxiety and neuropathic pain. The versatility of Lexaria’s DehydraTECH™ drug delivery platform is apparent, and its limitations are not yet known.

For more information, visit the company’s website at www.LexariaBioscience.com

• Federal four-year grant awarded to Ohio State University to fund research program with PBIO
• Goal is development of manufacturing process to keep foods fresh without costly refrigerated transport/storage and safe without chemical additives
• PBIO’s Ultra-Shear Technology (“UST”) allows food manufacturers to manufacture healthier beverages and other foods that retain flavor and preserve product’s wholesome ingredients, potentially affecting future food processing around the world
• Dairy alternative beverage market, which grew 18 percent from 2009 to 2014 to reach $18.9 billion, fueled by consumers seeking tasty, nutrient-dense, convenient options for on-the-go lifestyles
• Consumers increasingly value “clean-label” foods, with 73 percent stating that they would pay more for food or drink products made safely with recognizable ingredients
• Global dairy market projected at $442 billion by 2019 with a CAGR of six percent

Imagine food, such as milk, that doesn’t go bad, tastes like the fresh product, is free of chemical preservatives and doesn’t need expensive refrigerated transport or storage. Now, think of how many bottom lines of companies around the world such a technology could affect.

Global life sciences company Pressure BioSciences Inc. (OTCQB: PBIO) and its patented Ultra Shear Technology (“UST”) will be used to develop an innovative manufacturing technology in a new, federally-funded research program focused on food preservation and safety at Ohio State University’s College of Food, Agricultural and Environmental Sciences (“CFAES”). PBIO is a Massachusetts-based company that manufactures high-pressure-based equipment and laboratory instrumentation for the life science industry. CFAES is a worldwide leading food safety college.

PBIO’s Ultra Sheer Technology produces highly stable, clean and cost-effective nanoemulsions that facilitate the production of food products with enhanced shelf lives and without the need for chemicals or preservatives, as the company notes in a recent article (http://ibn.fm/V4Vja). The UST technology, which aligns with consumer demand for chemical- and preservative-free products, can be applied across many industries, including pharmaceutical, food, nutraceutical, industrial lubricant, paint and cosmetic sectors.

Researchers at Ohio State and their PBIO collaborators announced the U.S. Department of Agriculture’s National Institute of Food and Agriculture four-year $891,000 grant in a recent news release (http://ibn.fm/LEBPF). PBIO’s UST technology will be the basis upon which a new manufacturing technology will be developed to preserve food and beverages by reducing thermal exposure through the combined application of elevated pressure, shear, controlled times and temperatures.

A growing need to optimize processing technologies to preserve the freshness of foods while extending the shelf life without using preservatives is a key factor for researchers in this demanding, developing global market. Statista reports that, for example, the dairy market worldwide, valued at $336 billion in 2014, is projected to grow by six percent to reach a staggering $442 billion in 2019 (http://ibn.fm/RjYQx). For dairy-alternative consumers, the market is just as intriguing, with a strong demand that reached $18.9 billion by the end of 2014 as dairy-based sports nutrition drinks gained in popularity (http://ibn.fm/SmXH1).

V.M. Dr. “Bala” Balasubramaniam, a CFAES professor of food engineering, is leading the development project, which is designed as a collaborative team effort with scientists and engineers at PBIO. Balasubramaniam believes that UST also holds the potential to be utilized by food manufacturers to ensure a healthier processing of sauces, condiments and other foods.

“Development of cost-effective, next-generation, gentler industrial food manufacturing technologies for the preservation of healthy beverages has now become a critical need,” Balasubramaniam stated in the university’s news release.

Edmund Ting, a senior vice president at PBIO, will lead the development of the laboratory scale and pilot plant equipment that CFAES and the company’s researchers will use in the project. The UST equipment developed under the project will be used to demonstrate the UST-based processing method to the beverage and food processing industry through pilot plant demonstrations and testing at the university’s advanced technology pilot plant on campus.

“It has been rewarding to see the significant growth of high-pressure food and beverage processing over the last 25 years,” Ting stated in the news release. “I believe UST has equal if not greater applications than high-pressure processing, both within and outside the food and beverage industries.”

The high-pressure processing equipment market is projected to reach $500.3 million by 2022 at a CAGR of 11.26 percent from 2016, according to a report from MarketsAndMarkets (http://ibn.fm/9fZM9). North America and European regions dominated this market in 2015 and are expected to continue leading as early adopters of new food processing technologies, the report states.

Consumers are increasingly looking for foods and beverage products that they believe are genuine and free of preservatives, with 73 percent stating that they would pay more for a product they trust, a Food Insider Journal article states (http://ibn.fm/R67ID). These “clean label” products brought in global sales of $165 billion in 2015 and are expected to reach $180 billion by 2020. The UST-based processing method being developed by Ohio State and PBIO will be a new alternative to existing options, one that will not use high heat and will consequently offer the potential for better taste, nutritional value and safety.

“We are pleased to collaborate with experts at Ohio State to advance the commercialization of the UST platform for the food and beverage market,” Ting added, noting that the UST equipment developed with the grant will eventually be shared with the food and beverage industry through pilot plant demonstrations and testing, webinars, short courses and food processor fact sheets.

“The UST technology is expected to be particularly beneficial for medium- and small-scale food processors and entrepreneurs who otherwise have limited technical resources to evaluate such novel food manufacturing processes,” Balasubramaniam said. “The ultimate goal is for consumers to benefit from the increased availability of wholesome, healthy beverage and food options.”

For more information, visit the company’s website at www.PressureBioSciences.com

• Company to work with Cavitation Technologies to raise efficiencies in oil extraction process
• Collaboration aimed at decreasing Petroteq’s production costs
• Petroteq applies for uplisting to Nasdaq exchange

Oil and gas company Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is partnering with a leading fluids processing company to test ways of improving oil yields in Petroteq’s oil sands extraction process. Cavitation Technologies, Inc. (OTCQB: CVAT) (“CTi”), which develops technologies used in various industries, is to work with Petroteq to analyze the efficiency of its workflow processes and ultimately decrease production costs, according to a Petroteq news release (http://ibn.fm/A4rvr).

Petroteq is on the verge of beginning full scale extraction of oil from oil sands in its facility at Asphalt Ridge, Utah. Using its patented, environmentally-friendly technology, Petroteq expects to extract 1,000 barrels of oil per day when the facility hits full capacity in August. Petroteq’s innovative methods will allow it to extract oil without leaving behind waste or releasing greenhouse gases. The company has leased 2,541 acres and 87.49 million barrels of mineable oil sands in Utah.

“We are excited to be partnering with CTi. With our recent upgraded facility site, we are now exploring opportunities to make our products more cost-effective and efficient. We feel that it is important to engage on the innovation of our R&D with other compelling technologies that have the potential of generating scalable solutions within the industry,” Petroteq CEO David Sealock stated in a news release.

CTi Founder and Global Technology Manager Roman Gordon explained that his company has introduced its proprietary technology in a number of different verticals while creating partnerships with industry leaders over the last decade. “This agreement provides our companies the opportunity to develop and implement technologically advanced processes that will greatly improve efficiencies over conventional methods while achieving increased margins and profitability,” he added.

Under the agreement, Petroteq and CTi will use CTi’s proprietary Nano Reactor System™ to raise the value and yield of oil extracted from oil sands. According to the press release, the technology can influence and alter the chemical and physical composition of certain crude oils and hydrocarbon substances so as to enhance the economic value and yield of refined oils and related hydrocarbon products.

In what has proved to be an eventful summer for Petroteq, the company has applied to have its stock listed on the Nasdaq Capital Market (http://ibn.fm/wlt37). The company hopes that, if approved, listing on the Nasdaq will raise its visibility with investors and increase awareness of Petroteq in the financial community.

“We believe that a NASDAQ listing will help unlock some of the shareholder value we are trying to create for our stakeholders. A NASDAQ listing should provide us with more liquidity and a larger pool of investors that use the NASDAQ Stock Market as a requirement for assembling a portfolio,” Sealock said.

While the application is being processed, Petroteq stock will continue to trade as usual on the OTC market in the U.S. and on Canada’s TSX Venture Exchange, as well as markets in Frankfurt, Berlin, and Munich.

For more information, visit the company’s website at www.Petroteq.energy

• Received $7.55 million institutional investment to support growth
• Setting the standard for global cross-channel payments acceptance and value-added service offerings
• Global business-to-business sales estimated at $7.7 trillion compared to $2.3 trillion business-to-consumer market
• Executed several complex initiatives in 2017, continued to deliver double-digit percentage organic growth year-over-year
• Total transactions processed by NETE during first six months of 2018 at $50.2 million, up from $35.7 million during same period of 2017

Global financial services, technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) continues increasing profitability with a strong track record that includes processing transactions in over 50 countries and coming “close to the $3 billion mark” with over 154 million transactions, Net Element CEO Oleg Firer stated in an exclusive interview with NetworkNewsAudio (http://ibn.fm/UhMwq).

Key to this growth is the company’s next-generation Netevia platform that offers a smart solution that enables secure vendor payment transactions and streamlines business-to-business (“B2B”) transactions. Global B2B e-commerce gross sales are estimated at nearly $7.7 trillion compared to the $2.3 trillion business-to-consumer (“B2C”) market, according to Statista (http://ibn.fm/stEPr).

The company’s Netevia platform streamlines B2B payments by improving vendor payment processes and reducing the costs to send payments through a user-friendly web and mobile platform interface. This streamlined transaction platform, developed for small and medium-sized businesses, brings comprehensive and innovative card payments-oriented solutions that enhance operations by enabling vendor payments.

With Netevia, business owners can safely integrate payment acceptance into their unique ecommerce solutions, allowing users to manage their vendors, process payments and handle invoices with existing accounting systems. Merchants can streamline their own processes, including marketing tools, payment mechanisms and point-of-sale devices, and can add features as needed. Payment solutions between vendor sales is also supported by Netevia (http://ibn.fm/aVL5K), and tech support is available at any time by phone, email or web chat – a critical benefit when dealing with international business ventures.

Businesses that use Netevia, which was launched in February 2018, can accept over 100 cashless payment methods in nearly two dozen currencies. Net Element is well positioned in 2018 following a $7.55 million institutional investment to support growth and the launch of a business unit focused on blockchain technology solutions that will empower users to create decentralized, customized payment products, accept cryptocurrency in a multi-channel environment without having to pay high fees, develop loyalty programs and more (http://ibn.fm/vEDiP).

For more information, visit the company’s website at www.NetElement.com

• Mike Haridopolos, former president of the Florida State Senate, joins advisory board
• Green platform still at the core of REFG’s operations
• Strategically expanding through seed-to-sale services

Medical Cannabis Payment Solutions (OTC: REFG) recently announced the addition of Mike Haridopolos, former president of the Florida State Senate, to the company’s advisory board. Haridopolos brings a wealth of experience, education and national respect to the board. He is a former college professor of political science and history, has authored three books on politics and has served in both Florida’s House and Senate. Jeremy Roberts, CEO of REFG, and Curt Bramble, the advisory board’s chair, both expressed their excitement.

In a news release, Roberts stated, “With his experience working on Florida’s legislation, working to solve the prescription drug crisis and his experience in politics cross the nation, he helps us expand our footprint and will help us achieve our corporate objectives.” He joins an already strong advisory board consisting of former Oregon State Sen. Bruce Starr, former U.S. vice presidential Libertarian candidate James Gray, former New Mexico Gov. Gary Johnson and Curt Bramble, current president pro tempore of the Utah State Senate (http://ibn.fm/QVqKI).

REFG is a first-tier merchant processing cannabis industry pioneer, offering one of the first and only comprehensive card processing operations of its kind to serve the state-sanctioned medical marijuana industry. The company’s state of the art system tracks sales and tax collection, eliminating the need to deal in cash-only transactions. Bank support is often limited or non-existent due to federal regulations that are still in place. REFG’s “Green” platform allows merchants to sign up for these unique services online while guaranteeing FinCEN compliance.

While payment solutions remain at the core of REFG’s services, the company continues to strategically expand through diversified services that promise higher product quality in a seed-to-sale model. The company is working to acquire land and licenses in three states to grow industrial hemp through its newly acquired Colorado-licensed SpeedyGrow. It is looking at properties for purchase in Vermont, and has acquired 40 acres in Utah for the purpose of growing industrial hemp. Through SpeedyGrow, REFG is partnering with local Colorado hemp farmers and providing SpeedyVeg, an organic soil accelerator, to maximize crops.  Once harvested mobile hemp CBD extraction labs are being deployed to the farms. These labs improve processing efficiency, reduce energy consumption, eliminate redundant costs and provide a higher level of control over product quality. These farms are either owned and operated by REFG or have entered into processing agreements with the company. Once the CBD is extracted, merchant clients can utilize the Green platform for a one-of-a-kind client management and payment solution.

The addition of Haridopolos to REFG is one of many strategic moves to diversify, grow and better serve the cannabis industry.

For more information, visit the company’s website at www.Take.Green

• PreveCeutical was recently featured in an interview by Proactive Investors
• The company is currently developing its Sol-gel drug delivery platform for delivery of cannabinoids
• Sol-gel technology is paving the way for direct nose-to-brain drug delivery

Innovative health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) was recently featured by Proactive Investors in a “Corporate News Update” regarding the company’s potentially game-changing Sol-gel drug delivery platform (http://ibn.fm/ryrqu).  The company earlier provided a written press release updating the Sol-gel program (http://ibn.fm/Bww8y).

Sol-gel, a nickname for soluble gel, is taken through nasal (systemic) administration and quickly gels once it comes in contact with the mucosal tissue, paving the way for direct nose-to-brain delivery of drugs and effectively bypassing the stomach and intestines. This eliminates first-pass metabolism and could dramatically enhance bioavailability – even in comparison with nasal sprays and other newer drug delivery systems. The gel stays in the nasal passages and slowly releases its drug formulation while keeping it active for up to seven days. These long-lasting effects, coupled with easy application, offer great attraction as a drug delivery vehicle for patients.

PreveCeutical’s breakthrough Sol-gel technology is currently being tested in connection with various cannabis strains for the development and eventual commercialization of cannabinoid-based Sol-gel products. The company’s Sol-gel research and development program uses five distinct Cannabis sativa L. strains that contain a broad array of CBD:THC concentrations, enabling the development of medical cannabis products designed to treat various ailments and diseases. PreveCeutical’s current focus for the Sol-gel program is on developing Sol-gel formulations that contain fixed CBD:THC concentrations that, when sprayed using a custom applicator, can consistently and safely deliver CBD:THC in predefined ratios to the central nervous system.

Prior to obtaining medicinal cannabis import permits and licenses, which PreveCeutical achieved earlier this year, the company laid the framework for its Sol-gel program by evaluating the non-cannabinoid elements of commercially sourced cannabis plants and assessing the viability of incorporating them into the Sol-gel delivery platform. Through this preliminary screening of non-cannabinoid elements, PreveCeutical gained increased understanding regarding how components (other than CBD and THC) affect the formulation of Sol-gel systems, along with insight into the chemical compatibility, physiochemical stability and biocompatibility of Sol-gels with biological membranes. This has paved the way for optimization of engineered Sol-gels that contain PreveCeutical’s target gelation and adherence properties.

Additionally, the company is in the process of developing a custom Sol-gel applicator. PreveCeutical’s research partner, The University of Queensland, has received multiple Sol-gel spray device prototypes from the company’s manufacturer. Evaluations are ongoing, but the preliminary results have been promising.

For more information, visit the company’s website at www.PreveCeutical.com

• Construction spending in U.S. is projected to exceed $1.42 trillion in 2021
• Homeownership rate in the U.S. continues to decline while median price of new homes sold rose to $384,900
• Lack of affordable housing is termed a “crisis” in communities nationwide
• The company’s energy efficient, lightweight concrete technology is a cost-effective, structurally superior design created for commercial, residential projects

Auscrete Corp. (OTC: ASCK) is a building products manufacturer of environmentally-friendly, energy-efficient housing and commercial structures using a lightweight hybrid concrete material developed through a proprietary technology. Auscrete’s unique process produces a medium that is cost-efficient, extremely soundproof, offers high insulation values, requires very low maintenance, won’t burn, non-toxic, highly resistant to insects and mold, and resists damage from hurricane forces and earth tremors. It’s a more affordable, energy-efficient “green” construction material that can be utilized for building residential housing and commercial structures.

Affordable homes are increasingly becoming more difficult to purchase in the U.S. with the median price of a new home consistently rising while wages stay stagnant in many areas and mortgage rates rise. The average price of new homes sold in the U.S. in 2017 was nearly $385,000, according to Statista. The homeownership rate in the U.S. has been in decline since 2004, the report states, and now amounts to a little more than 64 percent of Americans.

Auscrete’s lightweight concrete product is described as an aerated concrete material following infusion of a specially designed foaming agent during manufacture. This technology enables the product to have millions of minuscule air bubble “aggregates” introduced and evenly distributed throughout the cast sections, which creates a unique, lightweight product without compromising strength or structural integrity. Each hybrid panel also incorporates a distinctive XPS insulation amalgamation that guarantees greater comfort in a wide range of climatic conditions and a reduction in heating and cooling costs. The final product is a light and strong concrete panel with an extremely high insulation value, as well as excellent fire resistance and sound-proofing qualities.

Auscrete’s product also offers a high strength-to-weight ratio, allowing architects and engineers to develop new design and construction concepts that take advantage of the product’s reduced weight, which is nearly half that of normal concrete. Each panel can be cast in large sections, a common size being 16-feet by 8-feet, for easier transportation and faster construction on site. Savings are enhanced, not only by the energy efficiency of each panel, but through the use of mass production techniques. Auscrete estimates the company can produce a ready-to-move-in turnkey house for around $100 per square foot, which is significantly less than the 2017 median list price of $148 per square foot in the U.S., according to a report by Zillow.

Auscrete is constructing its flagship, 10-acre facility in Goldendale, Washington, on initially 5 acres the company recently purchased with the option to purchase another 5 adjacent acres. This new campus will ultimately comprise of 6 buildings, including 3 production buildings of 25,000 sq. ft. with each production buildings’ capacity of 100 homes annually, giving this flagship facility the ability to produce 300 homes or equivalent commercial structures per year.

During this construction phase, Auscrete has leased a commercial building in Goldendale. The facility will be used as a temporary headquarters and will also serve as a refurbishing station for production equipment the company has developed and used in its prior production plant. John Sprovieri, CEO and founder of Auscrete Corporation, is at the helm of the company with Mike Young serving as vice president of internal operations and Otto Paulette controlling the in-house mechanical services.

Auscrete’s Investor Relations Director, Lee Odom said, “The company’s construction process has already attracted interest from many developers, contractors and builders, some with large tracts of land looking to make available, significant numbers of Affordable Homes throughout the Country. Additionally, there have been significant commercial projects offered including 300 room destination hotel resorts, correctional facilities, a shopping complex, and a court house along with a flood of inquiries from people who are looking for more affordable building options”.

“This could really launch the commercial aspect for ASCK, apart from residential home production which so many investors are not yet aware of,” Odom said. “A strong combination of both will lead ASCK to better performance through all business cycles, thus continuing to enhance the shareholder values, which is always the ultimate goal of Auscrete Corporation.”

For more information, visit the company’s website at www.AuscreteHomes.com

• Designing and powering Hyperledger blockchain technologies
• Creating solutions for sectors highly reliant on supply chain transparency and efficiency
• Business model allows for the creation of several wholly owned subsidiaries
• Working relationship with IBM provides expertise on supply chain implementations
• Management has more than 50 years of combined experience in finance, M&A, investments and more
• Advisory team led by Dr. Wang-Chan Wong, a 25-year veteran of global IT enterprise

Pacific Software Inc. (OTC: PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture, cannabis, and the opioid epidemic.

The basic requirements of the systems to be developed include high-throughput transaction processing, traceability or tracking, visibility or monitoring, and transparency throughout the supply and value chains for the stakeholders. The development of this architecture will serve as an online commercial portal to service Pacific Software’s B2B accounts in the sectors below.

Agriculture

For application of its Agri-blockchain based system, Pacific Software will target farm-to-consumer exports to increase transparency, combat theft and counterfeit products, and reduce the health risks associated with shipping “tainted” agricultural products to other countries.

Cannabis

Perceiving blockchain as an ideal mechanism for the complexities of the cannabis industry, Pacific Software will strive to improve the transparency, compliance, and efficiency of the “seed-to-sale” supply chain in states where the plant is legal.

Controlled Substances

With the misuse of opioids on the rise worldwide, Pacific Software aims to apply its blockchain-based system to track opioids from pharmaceutical production to consumers and attempt to identify “Bad Actors” in the supply chain and fight against the global epidemic.

Business Model

The portal will be structured in a B2B format where clients will pay the company transaction fees, royalties, cash, cash equivalents and other forms of compensation to utilize its Hyperledger blockchain applications for their business models.

As the company executes these strategies, each Hyperledger blockchain-based system designed may be organized separately in wholly owned subsidiaries. To enhance its portfolio of holdings, Pacific Software may consider investments in companies where selected markets have imminent profitable results, providing appreciable value for investors and shareholders.

For more information, visit the company’s website at www.PacificSoftwareInc.com

• World Crypto Con to award six university teams with opportunity to present blockchain research and projects
• Online applications accepted until August 31, with winners being revealed on October 1
• Conference to feature over 5,000 attendees and more than 150 exhibitors

World Crypto Con (“WCC”), the cryptocurrency and blockchain industry’s most immersive and interactive conference experience, this morning announced its inaugural University Research Showcase Scholarship. Per the update, the scholarship will award six university teams the opportunity to present their cutting-edge blockchain research and projects to more than 5,000 attendees at World Crypto Con, which is set to take place at the Aria Hotel and Casino in Las Vegas from October 31 to November 2.

“The future of blockchain holds unlimited opportunities and we’re excited to give university students a global stage to showcase their forward-thinking applications of this emerging technology and how it will change the world,” Adam Williams, co-founder of WCC, stated in the news release. “The challenge for these scholarship applicants is to present innovative and actionable concepts for blockchain that, if selected, they will present on the largest stage in blockchain, to the most notable leaders and pioneers in the space.”

WCC’s university scholarship is designed to provide future blockchain entrepreneurs with a global stage for their research, and the awards that are in store for winners reflect this mission. As noted in this morning’s update, winners will receive free entry to World Crypto Con for up to four team members, an exhibit booth space, a designated panel to share their projects and publicity on WCC’s website leading up to the conference. Winners will also have an opportunity to make connections with potential partners through the event’s series of networking sessions, educational programming and influencer meetups.

Those interested in applying can do so now by visiting the online application; submissions will be accepted until August 31. The top 10 finalist teams will be announced on September 17, with a community voting round being used to select the winners. The six winning entries are expected to be revealed on October 1.

WCC is hailed as “The Future of Bitcoin, Blockchain and Cryptocurrency Conferences” with its focus on bringing mass adoption of cryptocurrency and blockchain technology through small, medium and enterprise business innovation. In addition to top keynote speakers, non-stop education and networking opportunities, WCC will feature over 5,000 attendees, 150+ exhibitors and roughly 200,000 square feet of meeting and exhibit space.

For more information on World Crypto Con, visit the event’s website at www.WorldCryptoCon.com